View Day Schedule

Wednesday, November 20, 2024 Print Current Day:

SESSION 23 SCHEDULE
Wednesday SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI Location: Grand Ballroom East, 3rd Floor Moderators:Enrico Ascher, MD / Andrej Schmidt, MD / Christopher K. Zarins, MD
x
6:40 AM - 6:45 AM	How Do Prior Endovascular Interventions Affect Future Lower Extremity Bypass Outcomes For CLTI: Why Do The Results Of The BEST-CLI Trial Make This More Important
	Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Grand Ballroom East, 3rd Floor
6:46 AM - 6:51 AM	The Effect Of Optimal Medical Therapy On Outcomes In Patients With CLTI In The BEST-CLI Trial: What Should This Therapy Be And How Should It Be Monitored
	Presenter(s):Vik S. Kashyap, MD Location: Grand Ballroom East, 3rd Floor
6:52 AM - 6:57 AM	Five-Year Mortality In Medicare Patients Undergoing Interventions For CLTI And IC Is Worse Than We Thought: 67% For CLTI And 33% For IC
	Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS Location: Grand Ballroom East, 3rd Floor
6:58 AM - 7:03 AM	DEBATE: An Endo First Approach Is Best For Treating CLTI In Almost All Patients: The Role For Open Bypasses Is Very Limited (What Percent): Why BEST-CLI And BASIL 2 Have Not Changed My Practice
	Presenter(s):Christopher J. Abularrage, MD Location: Grand Ballroom East, 3rd Floor
7:04 AM - 7:09 AM	DEBATE: Open Bypass Should Be The First Treatment For Many CLTI Patients: When Is This So And In What Percent Of CLTI Patients
	Presenter(s):Michael S. Conte, MD Location: Grand Ballroom East, 3rd Floor
7:10 AM - 7:15 AM	Is The Open Surgery First Or Endovascular First Approach Controversy Still Alive For CLTI: What Percentage Of An Interventionalist's Patients Should Be Treated First By Open Surgery
	Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
7:16 AM - 7:21 AM	What Causes Small Foot Arteries To Have Decreased Blood Flow Resulting In CLTI: Medial Arterial Calcification (MAC) Causes Increased Vascular Stiffness And Decreased Blood Flow; Atheromatous And Non Atheromatous Lesions Further Obstruct Blood As Shown Pathologically: Can Any Of These Be Treated
	Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor
7:22 AM - 7:27 AM	What Are The Best Current Techniques For Revascularizing BTK And Below-The-Ankle (BTA) Lesions Causing CLTI: Is Open Bypass Ever The Best
	Presenter(s):Stefan Müller-Hülsbeck, MD Location: Grand Ballroom East, 3rd Floor
7:28 AM - 7:33 AM	Microembolization During Complex Endovascular Procedures Is Causing More Damage Than We Think To The Already Compromised Pedal Runoff: Is Paclitaxel A Causal Agent
	Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
7:34 AM - 7:39 AM	Is Preop CT Fractional Flow Reserve (FFR_CT) Guided Coronary Revascularization Beneficial In Patients Requiring Invasive Treatment For Lower Extremity (LE) Lesions: An RCT Comparing Standard Care Versus Such Revascularization Is Showing The Benefit Of The Latter: What Is The Best Time For The Coronary Procedure—Before Or After The LE Treatment
	Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD Location: Grand Ballroom East, 3rd Floor
7:40 AM - 7:45 AM	Radial-to-Peripheral Interventions For Lower Extremity Arterial Lesions (PAD): An Update On Available Tools And Techniques And Precautions: What's Possible And What's Not
	Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor
7:46 AM - 7:53 AM	Panel Discussion
END OF SESSION 23

SESSION 24 SCHEDULE
Wednesday SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) Location: Grand Ballroom East, 3rd Floor Moderators:Craig M. Walker, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Peter A. Schneider, MD
x
PROGRESS IN ATHERECTOMY
7:53 AM - 7:58 AM	Which Vascular Specialists Are Performing Tibial Atherectomies And Angioplasties For Intermittent Claudication And Are There Suboptimal Outcomes: Is Atherectomy Usage Overall Being Abused
	Presenter(s):Caitlin W. Hicks, MD, MS Location: Grand Ballroom East, 3rd Floor
7:59 AM - 8:04 AM	Update On Atherectomy Devices: Do They Still Have A Role In 2024: Which One Or Ones Are Best: Has Their Benefit Been Proven
	Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom East, 3rd Floor
8:05 AM - 8:10 AM	Atherectomy In Patients With CLTI, In Stent Restenosis (ISR) And Diabetes: When Is It Helpful; How Durable Is It: Which Devices Are The Best
	Presenter(s):Ignacio Escotto, MD Location: Grand Ballroom East, 3rd Floor
8:11 AM - 8:16 AM	The Objective Benefits Of Directional Atherectomy In Treating Lower Extremity Occlusive Lesions Are Real: When And How Should It Be Used And When Should It Not
	Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor
8:17 AM - 8:22 AM	What Is The Evidence That Atherectomy Is Effective In Femoropopliteal Interventions
	Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom East, 3rd Floor
8:23 AM - 8:28 AM	3-Year Experience With The Rotarex Atherectomy And Thrombectomy System (From BD) For Arterial Occlusive Disease And ISR: How Does It Work And Advantages
	Presenter(s):Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor
DRUG ELUTING STENTS (DESs) FOR BTK LESIONS
8:29 AM - 8:34 AM	Update And 2-Year Results Of The LIFE-BTK Randomized Controlled Comparison Of Abbott’s Esprit Drug-Eluting Resorbable Stent (DERS) With Plain Old Balloon Angioplasty (POBA): When Will DERSs Make A Difference
	Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor
8:35 AM - 8:40 AM	Update On Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5 Years: From The DISAPEAR Registry And A Meta-Analysis Of Other Bioresorbable BTK Stent Results
	Presenter(s):Steven Kum, MD Location: Grand Ballroom East, 3rd Floor
8:41 AM - 8:46 AM	Updated Experience With Everolimus And Other Nonabsorbable DESs To Treat Infrapopliteal BTK Lesions – Long And Short – Causing CLTI: What Are The Stents And When Do They Help: Why Will The DERSs Be Better
	Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Grand Ballroom East, 3rd Floor
8:47 AM - 8:52 AM	Late-Breaking Final Patency And Wound Healing Results With A 3-French Compatible Microstent (From Micro Medical) Versus POBA For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: From The STAND RCT
	Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI / Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor
8:53 AM - 9:00 AM	Panel Discussion
END OF SESSION 24

SESSION 25 SCHEDULE
Wednesday SESSION 25: LOWER EXTREMITY TOPICS RELATED TO DRUG COATED BALLOONS (DCBs), AND DRUG ELUTING STENTS (DESs) AND OTHER INTERWOVEN (SUPERA) STENTS Location: Grand Ballroom East, 3rd Floor Moderators:Kenneth Ouriel, MD, MBA / Sahil A. Parikh, MD / Michael S. Conte, MD
x
9:00 AM - 9:05 AM	One View On The Final Result Of The Scare And Concern That Paclitaxel Coated Devices For Lower Extremity Treatments Increased Mortality And Amputation Rates: The Case Is Closed: What Were Its Costs
	Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
9:06 AM - 9:11 AM	Another View On The Final Word: Is There Still Any Validity To The Increased Amputation And Mortality Rate Signals After Use Of Paclitaxel Coated Devices In The Lower Extremity: How Can We Explain These Signals In Older Studies And Their Disappearance In More Recent Data: The Case Is Not Yet Fully Closed
	Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR Location: Grand Ballroom East, 3rd Floor
9:12 AM - 9:17 AM	Update On DCBs For BTK Angioplasty: RCT Comparing A Paclitaxel DCB (Litos From Acotec) Versus A Sirolimus DCB (Magic Touch From Concept Medical): Update On Enrollment And Data In The DEBATE BTK DUELL RCT And The XTOSI Study
	Presenter(s):Francesco Liistro, MD / Edward T. Choke, MBBS, PhD Location: Grand Ballroom East, 3rd Floor
9:18 AM - 9:23 AM	Progress With A Sustained Release Sirolimus DCB For FemPop Lesions: 1-Year Results With The Magic Touch DCB Compared To A Paclitaxel DCB: From The SIRONA Study
	Presenter(s):Andrej Schmidt, MD / Thomas Zeller, MD / Dierk Scheinert, MD / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
9:24 AM - 9:29 AM	Adventitial Drug Delivery With The BullFrog Device (From Mercator Medical) And The Spur Device (From ReFlow): How Do They Work And How Will We Know They Improve Results
	Presenter(s):William A. Gray, MD Location: Grand Ballroom East, 3rd Floor
9:30 AM - 9:35 AM	To Reduce Injury In Post Balloon PTA Dissections: The Value Of Stents, Tacks, Etc.
	Presenter(s):Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor
9:36 AM - 9:41 AM	Late Breaking Information Shows That Higher Dose Of Statins Greatly Lessens The Risk Of SFA Stent Restenosis: Is It True With DESs
	Presenter(s):Timothy W.I. Clark, MD Location: Grand Ballroom East, 3rd Floor
9:42 AM - 9:47 AM Power Point Presentation with Synched Audio	The Light And Darkness Of Fluoropolymer-Based Limus DESs In The Treatment Of Femoropopliteal Lesions
	Presenter(s):Osamu Iida, MD, PhD Location: Grand Ballroom East, 3rd Floor
9:48 AM - 9:53 AM	Updated And Long-Term Follow-Up Results With The Vasculomimetic Interwoven Supera Stent In Angulated And Tortuous Lower Extremity Anatomies
	Presenter(s):Rajiv Parakh, MBBS, MS, FRCS Location: Grand Ballroom East, 3rd Floor
9:54 AM - 9:59 AM Power Point Presentation with Synched Audio	Are DESs Ever Associated With Aneurysmal Degeneration: Is It Related To The Drug (Paclitaxel Or Limus) Or To The Fluoropolymer Excipient To Which The Drug Is Attached
	Presenter(s):Osamu Iida, MD, PhD Location: Grand Ballroom East, 3rd Floor
10:00 AM - 10:08 AM	Panel Discussion
10:08 AM - 10:18 AM	Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 25

SESSION 26 SCHEDULE
Wednesday SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs Location: Grand Ballroom East, 3rd Floor Moderators:John R. Laird, MD / Dierk Scheinert, MD / Sean P. Lyden, MD
x
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs
10:18 AM - 10:23 AM	How Should We Move Forward With Limus Coated Devices After FDA Has Cleared Paclitaxel Coated Devices: Are There Promising Results Currently With Limus Coated DCBs
	Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
10:24 AM - 10:29 AM	4-Year Results Of An RCT Comparing Surveil DCBs (Surmodics) With In.Pact DCBs (Medtronic) For Treating FemPop Lesions: From The TRANSCEND Trial
	Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
10:30 AM - 10:35 AM	2-3-Year Results Of The EMINENT RCT Show The Superiority Of DESs (Eluvia-Boston Scientific) Over Bare Metal Stents For Long Complex FemPop Lesions
	Presenter(s):Yann Gouëffic, MD, PhD Location: Grand Ballroom East, 3rd Floor
10:36 AM - 10:41 AM	Update On The Randomized Head-To-Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 5-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages
	Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD Location: Grand Ballroom East, 3rd Floor
10:42 AM - 10:47 AM	Update On The BioMimics 3D Spiral Flow Prosthetic Graft From Veryan Medical: Does It Prevent Neointimal Hyperplasia And Improve Patency: 3-Year Results With FemPop Lesions
	Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI Location: Grand Ballroom East, 3rd Floor
10:48 AM - 10:53 AM	One Year Results Of The SPORTS RCT – Comparing DESs (Eluvia – Boston Scientific) Versus Bare Metal Stents (BMSs) Versus DCBs: Which Device Is Best And In What Circumstances
	Presenter(s):Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor
10:54 AM - 10:59 AM	Updated 5-Year Results Of The IMPERIAL RCT Head-To-Head Comparison Of The Eluvia DES (Boston Scientific) With The Zilver PTX DES (Cook): Both Are Safe And Effective: What Are The Differences
	Presenter(s):Stefan Müller-Hülsbeck, MD / William A. Gray, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor
11:00 AM - 11:05 AM	New Findings From The DRASTICO Study Comparing DESs To DCBs For FemPop Lesions: 5-Year Results With TASC A/B Lesions Versus TASC C/D Lesions
	Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
11:06 AM - 11:11 AM	Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With De Novo Or Recurrent FemPop Lesions At 5 Years In The ILLUMENATE US And European RCTs
	Presenter(s):Sean P. Lyden, MD / Marianne Brodmann, MD / Sahil A. Parikh, MD / William A. Gray, MD Location: Grand Ballroom East, 3rd Floor
11:12 AM - 11:18 AM	Panel Discussion
NEW INFORMATION ON BTK DCBs AND DESs
11:18 AM - 11:23 AM	Why Some BTK DCB Trials Have Not Shown Uniformly Better Results: Technical And Balloon Factors Matter
	Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
11:24 AM - 11:29 AM	When, How And With What Devices Are Endovascular Treatments The Best Way To Treat BTK Disease Causing CLTI
	Presenter(s):Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor
11:30 AM - 11:35 AM	5-Year Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency Versus POBA To Treat BTK Lesions
	Presenter(s):Wei Guo, MD / Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
11:36 AM - 11:41 AM	Sirolimus DCBs For Infrapopliteal Interventions: The Cordis/MedAlliance Selution 4BTK IDE Trial Update: Overseas Results Have Been Promising
	Presenter(s):Patrick J. Geraghty, MD / George L. Adams, MD / Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor
11:42 AM - 11:47 AM	How Does The LIFE BTK Study With Esprit Bioresorbable DES (From Abbott) Change The BEST- CLI Conclusions For BTK Lesions
	Presenter(s):Lawrence A. Garcia, MD Location: Grand Ballroom East, 3rd Floor
11:48 AM - 11:53 AM	Below-The-Ankle Endo Interventions In 2024: Techniques, Devices And Should Balloons Be Drug Coated Or Not
	Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
11:54 AM - 12:00 PM	Panel Discussion
12:00 PM - 1:00 PM	Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 26

SESSION 27 SCHEDULE
Wednesday SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT” Location: Grand Ballroom East 3rd Floor Moderators:Richard F. Neville, MD / Marco G. Manzi, MD / Roberto Ferraresi, MD
x
1:00 PM - 1:05 PM	Successful Bypasses To Foot Arteries And Their Branches Allowed Limb Salvage In What Were Thought To Be 'No Option For Treatment' CLTI Patients
	Presenter(s):Enrico Ascher, MD / Frank J. Veith, MD Location: Grand Ballroom East 3rd Floor
1:06 PM - 1:11 PM	What Presently Defines A No Option Or Desert Foot Before Or After Failed Endo Or Open Treatments: Under What Conditions Are Further Extreme Limb Salvage Procedures Possible
	Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East 3rd Floor
1:12 PM - 1:17 PM	No Option CLTI Is Often A Misnomer: What Diagnostic And Therapeutic Procedures Can Result In Successful Limb Salvage In Many Of These Patients
	Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) Location: Grand Ballroom East 3rd Floor
VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES
1:18 PM - 1:23 PM	Why PTFE Bypasses To Infrapopliteal Arteries Have Been A Controversial Procedure For More Than 40 Years – And Why They Continue To Be
	Presenter(s):Matthew T. Menard, MD Location: Grand Ballroom East 3rd Floor
1:24 PM - 1:29 PM	Long-Term Multicenter Outcomes Show That Prosthetic (PTFE) Bypasses To Tibial And Peroneal Arteries Are Worthwhile
	Presenter(s):Hasan H. Dosluoglu, MD / Richard F. Neville, MD / Enrico Ascher, MD / Frank J. Veith, MD Location: Grand Ballroom East 3rd Floor
UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI
1:30 PM - 1:35 PM	Value Of Open Surgical Vein Arterialization: When And How It Can Be Useful: Technical Tips From The First One To Make It Work
	Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) Location: Grand Ballroom East 3rd Floor
1:36 PM - 1:41 PM	Why Foot Vein Arterialization Can Save Limbs With Truly No Other Option: What Is The Physiology That Allows Successful Arterialization Into Small Veins And The Capillary Bed: What Is Necessary For This To Occur
	Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East 3rd Floor
1:42 PM - 1:47 PM	Update On The PROMISE Trials And Registry Results In No Option CLTI Patients With Foot Gangrene Shows That Deep Vein Arterialization (DVA) Using The LimFlow Device Can Produce Wound Healing And Limb Salvage: When Does It Work And When Doesn’t It: Are There Drawbacks
	Presenter(s):Daniel G. Clair, MD / Hany M. Zayed, MD / Andrej Schmidt, MD / Daniela Branzan, MD Location: Grand Ballroom East 3rd Floor
1:48 PM - 1:53 PM	Technical Advances In (DVA) With The LimFlow Device: Improved Access, Better Post Procedural Care And Wound Management Are Essential
	Presenter(s):Anahita Dua, MD, MS, MBA Location: Grand Ballroom East 3rd Floor
1:54 PM - 1:59 PM	Technical Tips For DVA: The Most Important Part Starts After The Procedure
	Presenter(s):Erwin Blessing, MD Location: Grand Ballroom East 3rd Floor
2:00 PM - 2:05 PM	Deep Venous Arterialization (DVA): Advantages Of Open Surgical Versus Endovascular Procedures Based On A Single Center Experience
	Presenter(s):Richard F. Neville, MD Location: Grand Ballroom East 3rd Floor
2:06 PM - 2:11 PM	Novel Uses Of Selective Superficial Venous Arterialization To Achieve Lower Limb Salvage: Techniques, Indications, Precautions And Results
	Presenter(s):Patrick J. Geraghty, MD Location: Grand Ballroom East 3rd Floor
2:12 PM - 2:17 PM	Hybrid Superficial Venous Arterialization For No Option CLTI: Technical Tips: Causes And Patterns Of Failure - Which Is Common
	Presenter(s):Miguel F. Montero-Baker, MD Location: Grand Ballroom East 3rd Floor
2:18 PM - 2:24 PM	Panel Discussion
END OF SESSION 27

SESSION 28 SCHEDULE
Wednesday SESSION 28: NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR) Location: Grand Ballroom East, 3rd Floor Moderators:Timothy M. Sullivan, MD / Patrick J. Geraghty, MD / Anahita Dua, MD, MS, MBA
x
NEW CONCEPTS RE PTFE GRAFTS AND STENT-GRAFTS
2:25 PM - 2:30 PM	Heparin-Bonded Expanded PTFE Grafts For BTK Bypasses: What Is The Evidence That They Are Better And Are Propaten (Gore) Grafts The Best For Extensive FemPop Disease: Based On An RCT And A Systemic Review And Meta-Analysis
	Presenter(s):Yann Gouëffic, MD, PhD Location: Grand Ballroom East, 3rd Floor
2:31 PM - 2:36 PM	Less Invasive And More Effective Hybrid Method For Restoring Patency To Occluded PTFE Bypasses Using A Fluoroscopically Guided Adherent Clot Remover (From Edwards)
	Presenter(s):Neal S. Cayne, MD / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor
2:37 PM - 2:42 PM Power Point Presentation with Synched Audio	5-Year Results Of Viabahn Stent-Graft For Complex FemPop Lesions: Technical Tips, Advantages And Limitations
	Presenter(s):Osamu Iida, MD, PhD Location: Grand Ballroom East, 3rd Floor
PERCUTANEOUS FEMPOP BYPASSES
2:43 PM - 2:48 PM	3-Year Results With Percutaneous (PQ) Transvenous FemPop PTFE Bypasses Using The Torus 2 Endograft (From Endologix): How Is It Done And Updated Results From The US DETOUR Trial: Does It Have Limitations
	Presenter(s):Sean P. Lyden, MD / Daniel G. Clair, MD / Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
2:49 PM - 2:54 PM	5-Year Results With Percutaneous Transvenous PTFE FemPop Bypass (PQ From Endologix) The DETOUR 1 TRIAL: Will Open Bypasses Become Obsolete
	Presenter(s):Dainis K. Krievins, MD Location: Grand Ballroom East, 3rd Floor
2:55 PM - 3:00 PM	Percutaneous Extravascular FemPop PTFE Bypasses Without Traversing The Vein: Technique And 6-Year Experience In Patients: Is It More Cost Effective: What Are The Limitations
	Presenter(s):Pierre G. Sarradon, Docteur / Jean Pierre Becquemin, MD, FRCS Location: Grand Ballroom East, 3rd Floor
STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
3:01 PM - 3:06 PM	Treatment Of SFA In Stent Occlusions: Technique Of Direct Stent Puncture: And Value Of The Excimer Laser To Cross And Treat The Occlusions: How Is It Done And Advantages
	Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor
3:07 PM - 3:12 PM	What Are The Best Current Treatment Options For ISR: What Are The Results Including Recurrence Rates
	Presenter(s):Stefan Müller-Hülsbeck, MD Location: Grand Ballroom East, 3rd Floor
ROLE OF OPEN PTFE BYPASSES IN CLTI
3:13 PM - 3:18 PM	In The Endovascular Era, What Is The Current Role Of Open Bypasses In A Limb Salvage Program: What Percentage Of CLTI Patients Will Need One At Some Time In Their Course And What Percentage Of Those Will Require A PTFE Graft
	Presenter(s):Niten Singh, MD Location: Grand Ballroom East, 3rd Floor
3:19 PM - 3:39 PM	Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 28

SESSION 29 SCHEDULE
Wednesday SESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES Location: Grand Ballroom East, 3rd Floor Moderators:Brian G. DeRubertis, MD / Marco G. Manzi, MD / Frank J. Veith, MD
x
3:40 PM - 3:45 PM	An Important Multicenter Propensity Matched Comparison Of Endo Versus Open Infrainguinal Treatment For CLTI Shows That Open Treatment Is Superior And Supports The Main Finding Of BEST-CLI
	Presenter(s):Jean-Baptiste Ricco, MD, PhD Location: Grand Ballroom East, 3rd Floor
3:46 PM - 3:51 PM	How To Reconcile The Different Primary Outcomes And Main Conclusion Of The BEST-CLI And BASIL-2 RCTs
	Presenter(s):Michael S. Conte, MD Location: Grand Ballroom East, 3rd Floor
3:52 PM - 3:57 PM	How The Data From BEST-CLI And BASIL-2 Can Be Combined To Produce Conclusions Superior To Those Of Either Trial Alone
	Presenter(s):Alik Farber, MD, MBA / Andrew W. Bradbury, MD, FRCSEd / Matthew T. Menard, MD / Kenneth Rosenfield, MD Location: Grand Ballroom East, 3rd Floor
3:58 PM - 4:03 PM	New Subanalysis Findings From The BEST-CLI RCT Are Critically Important To The Treatment Of CLTI Patients: Open Surgical Bypass Operations Still Have A Critical Role: Open Versus Endo Treatment Of Infrapopliteal Disease: Does Endo Treatment Burn Bridges
	Presenter(s):Matthew T. Menard, MD / Alik Farber, MD, MBA / Kenneth Rosenfield, MD Location: Grand Ballroom East, 3rd Floor
4:04 PM - 4:09 PM	Findings From BASIL-3, An RCT Comparing Clinical And Cost Effectiveness Of 3 Treatment Modalities For CLTI From FemPop Disease: POBA Versus DCBs Versus DESs
	Presenter(s):Andrew W. Bradbury, MD, FRCSEd Location: Grand Ballroom East, 3rd Floor
METHODS FOR EVALUATING FOOT PERFUSION
4:10 PM - 4:15 PM	Foot Perfusion Measurements Are The Best Method To Evaluate Treatment Effectiveness For CLTI: What Methods Are Available And Best
	Presenter(s):Werner Lang, MD Location: Grand Ballroom East, 3rd Floor
4:16 PM - 4:21 PM	How And Why To Measure Foot Perfusion During And After Endo Treatments: Hyperspectral Imaging, O2 Sensors, Etc.: When Is The Angiosome Concept Helpful; When Not
	Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
4:22 PM - 4:27 PM	New Methods For Evaluating The Significance Of Lower Extremity Arterial Lesions And Foot Perfusion Using Fractional Flow Reserve (FFR) And MRI; How They Work And Their Value In Assessing Therapeutic Success
	Presenter(s):Bijan Modarai, PhD, FRCS Location: Grand Ballroom East, 3rd Floor
4:28 PM - 4:35 PM	Panel Discussion
END OF SESSION 29

SESSION 30 SCHEDULE
Wednesday SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI) Location: Grand Ballroom East 3rd Floor Moderators:Matthew T. Menard, MD / Caitlin W. Hicks, MD, MS / Thomas S. Maldonado, MD
x
INTERMITTENT CLAUDICATION (IC)
4:36 PM - 4:41 PM	At 2 Years After Endovascular Interventions For IC, Only 32% Of Patients Were Free From Recurrent IC: From A VQI Multicenter Study: What Are The Implications
	Presenter(s):Peter F. Lawrence, MD Location: Grand Ballroom East 3rd Floor
4:42 PM - 4:47 PM	Decreasing Unnecessary And Potentially Harmful Endovascular Procedures In Patients With IC Which Are Almost Never Justified And Should Not Be Reimbursed
	Presenter(s):Caitlin W. Hicks, MD, MS Location: Grand Ballroom East 3rd Floor
4:48 PM - 4:53 PM	Under What Circumstances Could Tibial Endo Interventions Possibly Be Justified For IC
	Presenter(s):Sahil A. Parikh, MD Location: Grand Ballroom East 3rd Floor
4:54 PM - 4:59 PM	When Do Outcomes For Lower Extremity Revascularization Justify Their Use For IC In Patients >80 And >90
	Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS Location: Grand Ballroom East 3rd Floor
5:00 PM - 5:04 PM	Panel Discussion
ACUTE LIMB ISCHEMIA (ALI) (SEE ALSO SESSION 63)
5:04 PM - 5:09 PM	When And Why Is ALI Best Treated By Open Surgery: When Are Endovascular Treatments Best
	Presenter(s):Peter Henke, MD Location: Grand Ballroom East 3rd Floor
5:10 PM - 5:15 PM	The PROMOTE-ALI Study Shows That Open Surgery Is Still Number One In The Treatment Of ALI
	Presenter(s):Katariina M. Noronen, MD Location: Grand Ballroom East 3rd Floor
5:16 PM - 5:21 PM	DEBATE: ALI Is Always Best Treated Endovascularly: Why And What Techniques May Be Required
	Presenter(s):Ali Amin, MD, RVT, FACS, FACC Location: Grand Ballroom East 3rd Floor
5:22 PM - 5:27 PM	DEBATE: When Is Open Surgery Required To Treat ALI: When Is Mechanical Thrombectomy And Thrombo-Aspiration The Best Treatment: When Should Lytics Be Used: Based On A Systematic Review And Meta-Analysis
	Presenter(s):Yann Gouëffic, MD, PhD Location: Grand Ballroom East 3rd Floor
5:28 PM - 5:33 PM	Characteristics Of All The Commercial Systems For Mechanically Removing Clot To Treat ALI: What Are The Advantages And Disadvantages Of Each
	Presenter(s):Jos C. van den Berg, MD, PhD Location: Grand Ballroom East 3rd Floor
5:34 PM - 5:39 PM	What Is New With Penumbra Indigo Clot Aspiration Systems: Improved Mechanical Catheter And Computer Based Clot Removal Indigo Systems: Modulated Pulsed Aspiration Technology (Lightning Bolt And Thunder Bolt) For The Treatment Of Acute Arterial Clot: How It Works And Why It Improves Clot Removal In Various Vascular Beds: Is Open Surgery Ever Needed
	Presenter(s):James F. Benenati, MD Location: Grand Ballroom East 3rd Floor
5:40 PM - 5:45 PM	New Findings From The STRIDE Multicenter Trial: Mechanical Suction Thrombectomy With The Indigo Aspiration System (Penumbra) Had Few Complications And Excellent Limb Salvage: When Was It Contraindicated And When Was Angioplasty, Stenting Or Bypass Necessary
	Presenter(s):Thomas S. Maldonado, MD Location: Grand Ballroom East 3rd Floor
5:46 PM - 5:51 PM	Endovascular Mechanical Thrombectomy Is Obviating The Need For Thrombolytics In ALI: What Devices Are Available And What Are Their Advantages And Limitations
	Presenter(s):Patrick E. Muck, MD, FACS Location: Grand Ballroom East 3rd Floor
5:52 PM - 5:57 PM	Time To Perfusion In ALI: Which Is Faster, Lightning Bolt 7 (Penumbra) Or Open Surgical Embolectomy: When Is Open Surgery Necessary In 2024
	Presenter(s):Sean P. Lyden, MD Location: Grand Ballroom East 3rd Floor
5:58 PM - 6:05 PM	Panel Discussion End of Program D
END OF SESSION 30

SESSION 31 SCHEDULE
Wednesday SESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND RIVAROXABAN Location: Grand Ballroom West, 3rd Floor Moderators:Caron B. Rockman, MD / Michael R. Jaff, DO
x
6:40 AM - 6:45 AM	Postop Myocardial Infarctions (MIs) In Vascular Patients: What Are The New Options For Diagnosis, Prevention And Treatment
	Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor
6:46 AM - 6:51 AM	What Is The Best Current Method For Evaluating The Heart In Patients Undergoing Open And Endo Vascular Surgery: When Is A Stress Test An Important Tool
	Presenter(s):David H. Stone, MD Location: Grand Ballroom West, 3rd Floor
6:52 AM - 6:57 AM	New Findings From The VOYAGER PAD And COMPASS RCTs With Low Dose Rivaroxaban (Xarelto [Janssen/J&J]) And Aspirin: How Do These Drugs Lower Major Adverse Limb And Cardiac Event Rates After Lower Extremity Revascularization (Endo And Open)
	Presenter(s):Marianne Brodmann, MD / Sebastian E. Debus, MD, PhD Location: Grand Ballroom West, 3rd Floor
6:58 AM - 7:03 AM	How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials
	Presenter(s):Anthony J. Comerota, MD, FACS, FACC Location: Grand Ballroom West, 3rd Floor
7:04 AM - 7:09 AM	DEBATE: LDL Cholesterol (LDL-C) Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful: What Does The Latest Evidence Show
	Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS Location: Grand Ballroom West, 3rd Floor
7:10 AM - 7:15 AM	DEBATE: Not So: Update On LDL-C Lowering With Statins And Other Drugs: They Are Proven To Stabilize And Shrink Plaques And Decrease Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death
	Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor
7:16 AM - 7:21 AM	The Risk Of Arteriosclerosis And Its Complications Are Increased By LDL Cholesterol (LDL-C) Levels, Elevated Lp(a) And Inflammation: What Are The Best Medical Strategies To Decrease These Parameters: Statins, Adjunctive LDL-C Lowering Drugs Inclisiran, Bempedoic Acid, Ezetimibe, PCSK-9 Inhibitors, Lepodisiran, Colchicine, Olezarsen, Etc.) And Anti-Inflammatories: How They Should Be Administered
	Presenter(s):Richard Bulbulia, MA, MD, FRCS Location: Grand Ballroom West, 3rd Floor
7:22 AM - 7:27 AM	Update On LDL-C Lowering During A Lifetime: How Low To Strive For With Intensive Drug Therapy: How Young To Start If High; How Old To Continue Statins: Why And How Often Should LDL-C Levels Be Measured
	Presenter(s):J. David Spence, MD Location: Grand Ballroom West, 3rd Floor
7:28 AM - 7:33 AM	An Interesting New Anti-Atherosclerosis Vaccine (AtheroVax): A Drug To Produce Lifelong LDL-C Lowering With A Single Gene Modifying Treatment: The Heart-1 Gene-Editing Trial: How Does AtheroVax Work
	Presenter(s):Nicholas Kipshidze, MD, PhD, DSc Location: Grand Ballroom West, 3rd Floor
7:34 AM - 7:42 AM	Panel Discussion
END OF SESSION 31

SESSION 32 SCHEDULE
Wednesday SESSION 32: CATHETER BASED TREATMENTS FOR RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, CORONARY DESs, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS Location: Grand Ballroom West, 3rd Floor Moderators:Ron Waksman, MD / Lindsay Machan, MD
x
UPDATE ON RENAL DENERVATION FOR HYPERTENSION
7:42 AM - 7:47 AM	Renal Denervation For Resistant Hypertension Really Works As Shown By RCTs: What Are The Techniques And Devices: When Should They Be Used
	Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom West, 3rd Floor
7:48 AM - 7:53 AM	The Role Of Pressure Wires And IVUS In The Assessment Of Renal Artery Stenosis In The Treatment Of Hypertension And Other Conditions
	Presenter(s):Lindsay Machan, MD Location: Grand Ballroom West, 3rd Floor
7:54 AM - 7:59 AM	How And Why Do Thoracic Endografts For TEVAR Negatively Affect The Blood Pressure And The Heart: Can A Compliant Endograft Prevent The Problem: Does This Problem Arise With EVARs
	Presenter(s):Juan C. Parodi, MD Location: Grand Ballroom West, 3rd Floor
OTHER TOPICS RELATED TO VASCULAR DISEASE AND ITS TREATMENT
8:00 AM - 8:05 AM	When And To What Level Can Postoperative Anemia Be Tolerated After Major Vascular Surgery: When Should It Be Corrected By Transfusion And Do Cardiac Comorbidities Make A Difference
	Presenter(s):Panos Kougias, MD, MSc Location: Grand Ballroom West, 3rd Floor
8:06 AM - 8:11 AM	New Developments In Methods To Prevent Kidney Damage From Iodinated Contrast Agents
	Presenter(s):Roxana Mehran, MD Location: Grand Ballroom West, 3rd Floor
8:12 AM - 8:17 AM	How Important Is Inflammation As Determined By C-Reactive Protein (CRP) Levels In Predicting Adverse Cardiac Events: What Drugs Can Lower This Risk
	Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor
8:18 AM - 8:23 AM	When Should Smoking Be Stopped Before AAA Repair; Before Lower Extremity Bypass: At Least 4 Weeks: Why Does The Duration Of Cessation Matter
	Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS Location: Grand Ballroom West, 3rd Floor
8:24 AM - 8:29 AM	In Patients Undergoing Carotid Endarterectomy (CEA), What Should Best Medical Therapy (BMT) Be: Should Clopidogrel Be Part Of This BMT And Should It Be Continued During The Perioperative Period
	Presenter(s):Timothy M. Sullivan, MD Location: Grand Ballroom West, 3rd Floor
8:30 AM - 8:35 AM	How To Manage Patients With Recent Coronary DESs Who Require Vascular Operations Or Interventions: What To Do About Antiplatelet Medications: How Long To Wait Before Stopping Safely: What To Do With Urgent Or Emergent Cases To Avoid DES Thrombosis
	Presenter(s):Caron B. Rockman, MD Location: Grand Ballroom West, 3rd Floor
8:36 AM - 8:42 AM	Panel Discussion
8:42 AM - 8:54 AM	Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 32

SESSION 33 SCHEDULE
Wednesday SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM (FOR IMPORTANT RELATED TALKS SEE SESSION 33 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHsymposium.org) Location: Grand Ballroom West, 3rd Floor Moderators:Timur P. Sarac, MD / Luis A. Sanchez, MD / Mark W. Mewissen, MD, FSIR, RVT
x
ALL ENDOLEAKS AFTER EVAR
8:54 AM - 8:59 AM	Update On The Optimal Management Of Endoleaks: Key Points From A Systematic Review
	Presenter(s):Bernardo C. Mendes, MD Location: Grand Ballroom West, 3rd Floor
9:00 AM - 9:05 AM	Dynamic CT Scanning – The Gold Standard For Evaluating Endoleaks: Technical Requirements And How To Make It Help In Diagnosis And Treatment
	Presenter(s):Alan B. Lumsden, MD, FACS Location: Grand Ballroom West, 3rd Floor
9:06 AM - 9:11 AM	How To Improve Endoleak Detection And Finding Its Source With Contrast Enhanced Sonography
	Presenter(s):Thanila A. Macedo, MD Location: Grand Ballroom West, 3rd Floor
TYPE 1 ENDOLEAKS
9:12 AM - 9:17 AM	Major Systemic Trauma Can Lead To High-Flow (Type 1) Endoleaks In EVAR Patients: Can They Occur With Endografts Fixed By Hooks Or Barbs And What Is The Best Treatment
	Presenter(s):Carlo Setacci, MD Location: Grand Ballroom West, 3rd Floor
9:18 AM - 9:23 AM	Update On Embolization Treatment For Type 1 Endoleaks After EVAR: Indications And Technical Tips To Make It Work Successfully: Contraindications
	Presenter(s):Robert A. Morgan, MD Location: Grand Ballroom West, 3rd Floor
9:24 AM - 9:29 AM	How Can Type I Endoleaks Cause Sac Pressurization (Endotension) Without Contrast Visualization: How To Detect And Treat It: What Else Can Cause Endotension
	Presenter(s):Kenneth Ouriel, MD, MBA Location: Grand Ballroom West, 3rd Floor
9:30 AM - 9:35 AM	How To Treat Type 1 Endoleaks After EVAR: When Cuff, When F/EVAR, When Chimney, When Open Conversion: What About Embolization
	Presenter(s):Matteo Orrico, MD / Nicola Mangialardi, MD Location: Grand Ballroom West, 3rd Floor
9:36 AM - 9:41 AM	Panel Discussion
TYPE 2 ENDOLEAKS AFTER EVAR
9:41 AM - 9:46 AM	Most Type 2 Endoleaks After EVAR Should Be Left Alone Because Treatments Have Poor Results, Have Complications And Do Not Improve Outcomes: What Are The Exceptions
	Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Grand Ballroom West, 3rd Floor
9:47 AM - 9:52 AM	When Should We Reintervene And Keep Reintervening For Persistent Type 2 Endoleaks: What Factors With Persistent Type 2 Endoleaks Are Predictors Of AAA Rupture
	Presenter(s):Naoki Fujimura, MD, PhD Location: Grand Ballroom West, 3rd Floor
9:53 AM - 9:58 AM	When Do Type II Endoleaks Cause Type I Endoleaks After Standard EVAR: How To Best Diagnose And Treat Them: Does One Need Proximal Aortic Control If Treatment Is Open Conversion
	Presenter(s):Randall R. De Martino, MD Location: Grand Ballroom West, 3rd Floor
9:59 AM - 10:04 AM	The Role Of Mural Thrombus In The Development Of Late Type II Endoleaks: How Best To Prevent Them And Treat Them
	Presenter(s):Natzi Sakalihasan, MD, PhD Location: Grand Ballroom West, 3rd Floor
10:05 AM - 10:10 AM	Patients On Anticoagulation Are More Likely To Develop Endoleaks After EVAR: How Does It Influence The Outcome Of Endoleak Treatment And Should It Be Stopped If Possible
	Presenter(s):Faisal Aziz, MD Location: Grand Ballroom West, 3rd Floor
10:11 AM - 10:16 AM	How Can 3D Fusion And ASSIST Guidance (GE) Help In Type 2 Endoleak Treatment By Any Approach: How To Do It
	Presenter(s):Mark W. Mewissen, MD, FSIR, RVT Location: Grand Ballroom West, 3rd Floor
10:17 AM - 10:22 AM	Panel Discussion
10:23 AM - 10:28 AM	Transcaval Approach For Endoleak Embolization: A Minimally Invasive Hot Needle Approach And Other Technical Tips Including How To Close The Aortic Access Site
	Presenter(s):Sean P. Lyden, MD Location: Grand Ballroom West, 3rd Floor
10:29 AM - 10:34 AM	Transgraft Treatment Of Type 2 Endoleaks After EVAR: When And How To Do It
	Presenter(s):James F. McKinsey, MD Location: Grand Ballroom West, 3rd Floor
10:35 AM - 10:40 AM	The Latest Advances In The Treatment Of Type 2 Endoleaks: A New Technique With The Taurus Device Will Be Better: What Is It And Results
	Presenter(s):Zvonimir Krajcer, MD, FACC Location: Grand Ballroom West, 3rd Floor
10:41 AM - 10:46 AM	Innovative Type 2 Endoleak Obliteration Via Collateral Networks: Technical Tips
	Presenter(s):Palma M. Shaw, MD, MBA, FACS, RPVI, DFSVS Location: Grand Ballroom West, 3rd Floor
10:47 AM - 10:55 AM	An Algorithm For Diagnosing And Treating Challenging Endoleaks After F/B/EVAR For TAAAs
	Presenter(s):Thomas F. Lindsay, MDCM, FRCS Location: Grand Ballroom West, 3rd Floor
10:56 AM - 11:00 AM	Panel Discussion
END OF SESSION 33

SESSION 34 SCHEDULE
Wednesday SESSION 34: ISSUES IMPORTANT TO VASCULAR SURGEONS/SPECIALISTS Location: Grand Ballroom West, 3rd Floor Moderators:Kim J. Hodgson, MD / Thomas L. Forbes, MD
x
11:00 AM - 11:05 AM	A Tribute To James S. T. Yao, MD, PhD (1932-2023)
	Presenter(s):Jon S. Matsumura, MD Location: Grand Ballroom West, 3rd Floor
11:06 AM - 11:11 AM	How Human Behavior – Even With Vascular Surgeons/Specialists – Is Controlled By Biases And Rationalizations: How To Overcome These And Perform Better
	Presenter(s):Scott L. Stevens, MD Location: Grand Ballroom West, 3rd Floor
ISSUES RE EVIDENCE BASED PRACTICE
11:12 AM - 11:17 AM	RCTs Are Too Often Underpowered With Other Serious Flaws: So They Are Misused As Evidence, Negatively Influencing Practice And Innovation In Health Care
	Presenter(s):Frans L. Moll, MD, PhD Location: Grand Ballroom West, 3rd Floor
11:18 AM - 11:23 AM	Why Systematic Reviews, Meta-Analyses And RCTs Can Be Misleading: What To Do About It: Does Current Wisdom Help
	Presenter(s):Janet T. Powell, MD, PhD Location: Grand Ballroom West, 3rd Floor
11:24 AM - 11:29 AM	Answering The Current Big Questions: Vascular Surgeons/Specialists Need To Develop High Quality Evidence To Improve Care: How And Why To Do It
	Presenter(s):Jens Eldrup-Jorgensen, MD Location: Grand Ballroom West, 3rd Floor
ISSUES IMPORTANT TO VASCULAR SURGEONS/SPECIALISTS
11:30 AM - 11:35 AM	How Can Vascular Surgeons/Specialists Become Successful Entrepreneurs: What To Do And What Not To Do
	Presenter(s):Jeffrey H. Lawson, MD, PhD Location: Grand Ballroom West, 3rd Floor
11:36 AM - 11:41 AM	The Distracted Surgeon: Lessons Learned From Running Multiple Rooms: Is It Really More Efficient Or A Bad Practice Resulting In Poor Patient Care
	Presenter(s):Patrick A. Stone, MD Location: Grand Ballroom West, 3rd Floor
ISSUES IN VASCULAR TRAINING
11:42 AM - 11:47 AM	Optimal New Training Paradigm For Vascular Surgeons: 0+5 Vascular Surgery Residency Followed By 2 Years Of Cardiac Surgery Residency Training: Why Is It Better Than 2 Extra Years Of Laboratory Research
	Presenter(s):Alan B. Lumsden, MD, FACS Location: Grand Ballroom West, 3rd Floor
11:48 AM - 11:53 AM	Obtaining Cardiac Surgery Training After Vascular Surgery Training: I Did It, So It’s Possible: Is It Worthwhile: Advantages And Disadvantages
	Presenter(s):Jennifer L. Perri, MD, MBA Location: Grand Ballroom West, 3rd Floor
11:54 AM - 12:00 PM	Panel Discussion
12:00 PM - 1:00 PM	Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 34

SESSION 35 SCHEDULE
Wednesday SESSION 35: RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE PLINIO ROSSI AND LINC COMPONENTS Location: Grand Ballroom West, 3rd Floor Moderators:Fabrizio Fanelli, MD, EBIR / Andrew Holden, MBChB / Carlo Setacci, MD
x
THE PLINIO ROSSI COMPONENT
1:00 PM - 1:08 PM	DES Versus DCB+BMS Versus BMS+DCB Versus DCB+DES: The Winner Is: Evaluation Of The Different Treatment Strategies With A Focus On The Now Increasingly Common Combination Of DCB Plus BMS
	Presenter(s):Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom West, 3rd Floor
1:08 PM - 1:16 PM	Uterine Transplantation and Pregnancy: A Star in the Sky
	Presenter(s):Pierfrancesco Veroux, MD Location: Grand Ballroom West, 3rd Floor
1:16 PM - 1:24 PM	The Knickerbocker Technique – an Underutilized and Highly Effective Strategy for False Lumen Management in Chronic Aortic Dissection
	Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom West, 3rd Floor
1:25 PM - 1:30 PM	Panel Discussion
THE LINC COMPONENT
Moderator(s): Dierk Scheinert, MD / Andrej Schmidt, MD / Daniela Branzan, MD
1:30 PM - 1:59 PM	PROGRAM TO BE DETERMINED
END OF SESSION 35

SESSION 36 SCHEDULE
Wednesday SESSION 36: MORE ISSUES IMPORTANT IN VASCULAR SURGERY: HISTORY, PRACTICE PATTERNS, VALUE OF GUIDELINES AND RCTs, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR Location: Grand Ballroom West, 3rd Floor Moderators:Jack L. Cronenwett, MD / Timothy M. Sullivan, MD / Jerry Goldstone, MD, FACS, FRCSEd
x
2:00 PM - 2:05 PM Power Point Presentation with Synched Audio	A Tribute To Hans-Henning Eckstein, MD, PhD (1955-2024)
	Presenter(s):Sebastian E. Debus, MD, PhD Location: Grand Ballroom West, 3rd Floor
VASCULAR HISTORY
2:06 PM - 2:11 PM	Einstein And Nissen: A New York Story About An AAA Wrapped In Cellophane
	Presenter(s):Frank J. Criado, MD Location: Grand Ballroom West, 3rd Floor
2:12 PM - 2:17 PM	The SVS Digital History Archive: What Is It, Why It Is Important And Should Vascular Surgeons Contribute To It And Use It
	Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd Location: Grand Ballroom West, 3rd Floor
2:18 PM - 2:23 PM	Multispecialty Vascular Care Departments Or Units Within Institutions Are Best For Patients And Physicians: How Should The Dominant Specialty And Leader Be Chosen: How Should Rewards Be Distributed
	Presenter(s):Barry T. Katzen, MD Location: Grand Ballroom West, 3rd Floor
VASCULAR SURGERY’S ROLE AND RECOGNITION
2:24 PM - 2:29 PM	Vascular Surgery's Identity And Role Is Usually In A Subservient Position Within A Heart And Vascular Unit: What Should Be Done To Correct This Inequity In The Interest Of Better Patient Care
	Presenter(s):Timur P. Sarac, MD Location: Grand Ballroom West, 3rd Floor
2:30 PM - 2:35 PM	Vascular Surgery Needs An Independent ABMS Approved Board And Associated RRC To Thrive As A Specialty In The Medical Hierarchy And To Have Its Value Appropriately Recognized
	Presenter(s):Sean P. Lyden, MD Location: Grand Ballroom West, 3rd Floor
2:36 PM - 2:41 PM	The Negative Impact Of Hospital Administrators On Vascular Surgery And Vascular Surgeons' Careers: Why Is It Happening, Why Is It Worse For Vascular Surgeons Than Other Specialists And What Can Be Done To Counteract It
	Presenter(s):Samuel R. Money, MD, MBA Location: Grand Ballroom West, 3rd Floor
2:42 PM - 2:47 PM	The Role Of Women In Vascular Surgery: What Has It Been And Where Is It Going
	Presenter(s):Cynthia K. Shortell, MD Location: Grand Ballroom West, 3rd Floor
2:48 PM - 2:56 PM	Panel Discussion
ISSUES RE THE CONFLICT BETWEEN ETHICS AND FINANCES
2:56 PM - 3:01 PM	Simultaneous Overuse And Undertreatment Of Patients With PAD And CLTI: Why The Problem Exists And What Should Be Done To Fix It
	Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom West, 3rd Floor
3:02 PM - 3:07 PM	Physician And Industry Responsibility In Overuse Of Technology (Atherectomy, CAS, EVAR, Etc.): Especially Important In View Of The Recent Media Spotlight On This Issue
	Presenter(s):Murray L. Shames, MD Location: Grand Ballroom West, 3rd Floor
UNIONIZATION FOR VASCULAR SURGEONS
3:08 PM - 3:13 PM	Why Vascular Surgeons Should Unionize: The Pros And Cons
	Presenter(s):Enrico Ascher, MD Location: Grand Ballroom West, 3rd Floor
3:14 PM - 3:19 PM	Racial And Ethnic Disparities In Clinical Trials And The Treatment Of CLTI: What Are The Causes And What Can Be Done About Them
	Presenter(s):Vincent L. Rowe, MD Location: Grand Ballroom West, 3rd Floor
3:20 PM - 3:32 PM	Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 36

SESSION 37 SCHEDULE
Wednesday SESSION 37: MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs) Location: Grand Ballroom West, 3rd Floor Moderators:Anton N. Sidawy, MD, MPH / Krishna Jain, MD / Michael L. Marin, MD
x
3:32 PM - 3:37 PM	Vascular Spinoff Revenue In Tertiary Healthcare Systems: Substantially More Downstream Benefits FROM Vascular Surgeons: How To Make Hospital Administrators Appreciate The Value Of Vascular Surgeons And Reward Them Appropriately
	Presenter(s):Joseph V. Lombardi, MD, MBA Location: Grand Ballroom West, 3rd Floor
3:38 PM - 3:43 PM	The Significant Burden Of Iatrogenic Vascular Injury On The Vascular Surgery Workforce At A Tertiary Care Center: What Can And Should Be Done To Offset This Problem
	Presenter(s):Caron B. Rockman, MD Location: Grand Ballroom West, 3rd Floor
3:44 PM - 3:49 PM	Current Medicare Reimbursement For Complex AAAs (F/B/EVAR) Is Inadequate For Physicians And Less Profitable For Hospitals: How Does It Harm Vascular Surgery
	Presenter(s):Samuel R. Money, MD, MBA Location: Grand Ballroom West, 3rd Floor
3:50 PM - 3:55 PM	How And Why Aortic And Lower Extremity Artery Gender Differences Matter In The Treatment Of Vascular Disease: What Can Be Done To Offset This Problem
	Presenter(s):Linda M. Harris, MD Location: Grand Ballroom West, 3rd Floor
3:56 PM - 4:01 PM	The Value Of Telehealth In Vascular Surgery: Reimbursement Issues And When Is It Misleading
	Presenter(s):Misty D. Humphries, MD, MAS Location: Grand Ballroom West, 3rd Floor
ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs
4:02 PM - 4:07 PM	The Ever-Changing Reimbursement For Lower Extremity Endovascular Therapies In Hospitals And OBLs: Why It’s Happening And Where Is It Going
	Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD Location: Grand Ballroom West, 3rd Floor
4:08 PM - 4:13 PM	Limb Preservation Centers: Benefit To Patients, Physicians And Health Care Systems: How To Create One
	Presenter(s):Krishna Jain, MD Location: Grand Ballroom West, 3rd Floor
4:14 PM - 4:19 PM	How Can OBLs Provide Good Vascular Care With Excellent Results, Be Profitable And Still Allow Vascular Surgeons To Only Work From 8 AM To 5 PM
	Presenter(s):Mark A. Mattos, MD Location: Grand Ballroom West, 3rd Floor
4:20 PM - 4:25 PM	How To Make Outpatient Vascular Treatment Facilities (OBLs, ASCs) Safe, Effective And Profitable Without Doing Unjustified Procedures: How Can They Make Uniquely Important Vascular Research Contributions
	Presenter(s):Christopher J. Kwolek, MD, MBA / Enrico Ascher, MD Location: Grand Ballroom West, 3rd Floor
4:26 PM - 4:32 PM	Panel Discussion
END OF SESSION 37

SESSION 38 SCHEDULE
Wednesday SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; IMPROVING VASCULAR CARE QUALITY; FIXING FALSE TESTIMONY; FLAWED PEER REVIEW; FDA IMPROVEMENTS; LEARNING HEALTH SYSTEMS Location: Grand Ballroom West, 3rd Floor Moderators:Sean P. Roddy, MD / Jack L. Cronenwett, MD / Kim J. Hodgson, MD
x
VASCULAR REIMBURSEMENT ISSUES
4:32 PM - 4:37 PM	What’s Happening With Vascular Surgeon Reimbursement In 2024 And What Are The Prospects For 2025: For Hospital And OBL Procedures
	Presenter(s):Sean P. Roddy, MD Location: Grand Ballroom West, 3rd Floor
4:38 PM - 4:43 PM	Current Medicare Reimbursement For Ch/EVAR And F/EVAR Is Inadequate: The Situation Is Untenable: How Did We Get There And Can The Problem Be Fixed
	Presenter(s):Clayton J. Brinster, MD Location: Grand Ballroom West, 3rd Floor
4:44 PM - 4:49 PM	Reimbursement For Vascular Procedures Under CMS Is Deeply Flawed And Subject To The Bias Of Others: It Results In Unethical Compensatory Behavior: What Can Be Done About It
	Presenter(s):Sean P. Roddy, MD Location: Grand Ballroom West, 3rd Floor
ISSUES RE QUALITY OF VASCULAR CARE
4:50 PM - 4:55 PM	New Developments In And Benefits From VQI Participation: It Will Make For Better Doctors And Vascular Care And It Will Cut Hospital Costs
	Presenter(s):Jens Eldrup-Jorgensen, MD Location: Grand Ballroom West, 3rd Floor
4:56 PM - 5:01 PM	The SVS/ACS Vascular Verification Program (VVP) To Assure Quality Vascular Care In Inpatient And Outpatient Programs: What Is It And How Will It Help Vascular Surgery
	Presenter(s):Anton N. Sidawy, MD, MPH Location: Grand Ballroom West, 3rd Floor
5:02 PM - 5:07 PM	How Can The Insurance Industry Improve The Quality And Appropriateness Of Vascular Care And Help Vascular Surgery Survive In A Competitive World
	Presenter(s):Russell H. Samson, MD, DFSVS, RVT, FACS Location: Grand Ballroom West, 3rd Floor
PUNISHING FALSE TESTIMONY
5:08 PM - 5:13 PM	How Do We Hold Physicians Who Provide False Or Misleading Testimony Against Vascular Surgeons Accountable: Has The SVS Committee On This Topic Ever Done Anything To Do What Should Be Done
	Presenter(s):O. William Brown, MD, JD Location: Grand Ballroom West, 3rd Floor
5:14 PM - 5:20 PM	Panel Discussion
PEER REVIEW RELATED ISSUES
5:20 PM - 5:25 PM	Our System Of Peer Reviews Is Flawed: Within Hospitals; Within Journal Reviews: How Might Artificial Intelligence (AI) Improve Them
	Presenter(s):Timothy M. Sullivan, MD Location: Grand Ballroom West, 3rd Floor
5:26 PM - 5:34 PM	What Is An Impact Factor For A Peer Reviewed Journal Or An Article: What Is Plum X And H-Index: How Are They Calculated And Why Are They Important: What Constitutes Plagiarism – It’s Not Simple (8-Minute Presentation)
	Presenter(s):Peter F. Lawrence, MD / Peter Gloviczki, MD Location: Grand Ballroom West, 3rd Floor
FDA RELATED ISSUES
5:35 PM - 5:40 PM	I Was From The Government And I'm Here To Help: FDA Resources To Assure Safe And Effective Medical Devices In Vascular Disease: What Is The LEAF Initiative To Assure That Trials Are Appropriate For FDA Approval
	Presenter(s):Robert E. Lee, MD / Philip P. Goodney, MD, MS Location: Grand Ballroom West, 3rd Floor
5:41 PM - 5:46 PM	Why Do IDEs Fail To Get FDA Approval: Updates To The FDA 510 (K) Program And Why They Are Important
	Presenter(s):Valerie M. Merkle, PhD Location: Grand Ballroom West, 3rd Floor
5:47 PM - 5:52 PM	Different Perspectives From Industry And The FDA Regarding The Importance Of Innovation, Engineering And Financial Rewards That Influence Innovation
	Presenter(s):Dorothy B. Abel, BSBME Location: Grand Ballroom West, 3rd Floor
5:53 PM - 5:58 PM	What Is A Learning Health System And Why Should It Matter To Vascular Surgery
	Presenter(s):Charles C. Miller, PhD Location: Grand Ballroom West, 3rd Floor
5:59 PM - 6:05 PM	Panel Discussion End of Program E
END OF SESSION 38

SESSION 39 SCHEDULE
Wednesday SESSION 39: MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INFLAMMATORY ANEURYSMS AND THEIR TREATMENT Location: Trianon Ballroom, 3rd Floor Moderators:Ramon Berguer, MD, PhD / Timothy A. Resch, MD, PhD
x
6:50 AM - 6:55 AM	A Novel Low Profile Stent Graft For The Treatment Of All Thoracic Aortic Segments: What Makes It Unique And Clinical Status
	Presenter(s):Francesco Setacci, MD Location: Trianon Ballroom, 3rd Floor
6:56 AM - 7:01 AM	Options For Left Subclavian Revascularization During TEVAR: Laser Fenestration, Open Bypass, Single Branch Device (Gore), Etc.: Advantages And Limitations Of Each
	Presenter(s):Timothy A. Resch, MD, PhD Location: Trianon Ballroom, 3rd Floor
7:02 AM - 7:07 AM	Challenges And Successes With Endografts In The Treatment Of Ascending Aortic Dissections (TAADs), Penetrating Ulcers And Pseudoaneurysms
	Presenter(s):Rodney A. White, MD Location: Trianon Ballroom, 3rd Floor
7:08 AM - 7:13 AM	DEBATE: The STABILISE Technique To Eliminate The False Lumen And Relaminate The Aorta Will Change The Treatment Of Acute And Subacute TBADs And Will Replace Most False Lumen Occlusion Devices And F/B/EVAR Treatments: How To Do It And Precautions
	Presenter(s):Igor A. Laskowski, MD, PhD / Heepeel Chang, MD Location: Trianon Ballroom, 3rd Floor
7:14 AM - 7:19 AM	DEBATE: Not So Fast! A Multimodular Approach To Treating Acute, Subacute And Chronic TBADs With TAAAs: Who Needs A F/B/EVAR; Who Needs A Candy-Plug Or Other Techniques
	Presenter(s):Tilo Koelbel, MD, PhD / Fiona Rohlffs, MD, PhD Location: Trianon Ballroom, 3rd Floor
7:20 AM - 7:25 AM	Outer/Inner/Upward Branches Or Fenestrations: Strategies For Complex Aortic Repair For Patients With Chronic TBADs: Advantages And Limitations Of Each
	Presenter(s):Bijan Modarai, PhD, FRCS Location: Trianon Ballroom, 3rd Floor
7:26 AM - 7:31 AM	Current Advances In The Treatment For Inflammatory Aneurysms: How Effective Are EVAR And TEVAR
	Presenter(s):Furuzan Numan, MD Location: Trianon Ballroom, 3rd Floor
7:32 AM - 7:37 AM	Update On The Experience With BeGrafts (From Bentley), A Balloon Expandable Covered Stent For Treating Aortic Coarctations, Aneurysms And Midaortic Syndrome: Advantages And Limitations
	Presenter(s):Elchanan Bruckheimer, MBBS Location: Trianon Ballroom, 3rd Floor
7:38 AM - 7:43 AM	Relay Custom Made Endografts (Terumo) For TEVAR, Scalloped, Etc.: When And Why Are They Advantageous And Do They Still Have A Role In View Of Other New Endografts
	Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS / Mo S. Hamady, MD, FRCR, EBIR, FSIR Location: Trianon Ballroom, 3rd Floor
7:44 AM - 7:51 AM	Panel Discussion
END OF SESSION 39

SESSION 40 SCHEDULE
Wednesday SESSION 40: MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs) AND THEIR TREATMENT Location: Trianon Ballroom, 3rd Floor Moderators:Rodney A. White, MD / Tilo Koelbel, MD, PhD
x
7:52 AM - 7:57 AM	Debranching Aortic Arch Branches: When And How To Do It; Technical Tips And How To Avoid Pitfalls
	Presenter(s):Bernardo C. Mendes, MD
7:58 AM - 8:03 AM	With TAADs When And How Should The Distal Aorta Be Treated By TEVAR Before Repair Of The Ascending Aorta
	Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD Location: Trianon Ballroom, 3rd Floor
8:04 AM - 8:09 AM	With TAADs Why And When Should TEVAR Of The Descending Thoracic Aorta Be Performed Prior To Open Type A Repair: Should The Procedures Be Staged
	Presenter(s):Mazin Foteh, MD Location: Trianon Ballroom, 3rd Floor
8:10 AM - 8:15 AM	Late Results Of Patients With TAADs Treated By Open Repair Of The Ascending Aorta And Arch With A FET And Completed By The STABILISE Technique Distally
	Presenter(s):Jean-Marc Alsac, MD, PhD Location: Trianon Ballroom, 3rd Floor
8:16 AM - 8:21 AM	With Chronic TBADs Laser Assisted Resection Of The Dissection Septum Or Membrane Creates A Single Lumen TEVAR Landing Zone: How Is This Technique Performed And Updated Results
	Presenter(s):Nuno V. Dias, MD, PhD / Bjõrn Sonesson, MD, PhD Location: Trianon Ballroom, 3rd Floor
8:22 AM - 8:27 AM	Panel Discussion
8:27 AM - 8:32 AM	Updated Experience For Precise TEVAR Placement In Or Near The Arch By Valsalva And PEEP (Munich Valsalva Maneuver): It Is Safe And Effective And Better Than Adenosine, Rapid Pacing And Caval Occlusion: How To Do It And Results
	Presenter(s):Nikolaos Tsilimparis, MD, PhD Location: Trianon Ballroom, 3rd Floor
8:33 AM - 8:38 AM	Updated 5-Year Results From The European Experience With The Novel Nexus Single And Double (Duo) Branched (OTS) Endovascular Devices (From Endospan) For The Treatment Of Zone 0 And 1 Aortic Arch Aneurysms: What Makes This Device Unique
	Presenter(s):Mario L. Lachat, MD Location: Trianon Ballroom, 3rd Floor
8:39 AM - 8:44 AM	Status And Results From The US TRIOMPHE Trial Of The Endospan Nexus Endograft (OTS) For Treating Complex Aortic Arch Lesions Including Chronic Dissections
	Presenter(s):Ross Milner, MD Location: Trianon Ballroom, 3rd Floor
8:45 AM - 8:50 AM	In Situ Fenestration For Endovascular Repair Of Aortic Arch Lesions: Does It Reduce Perioperative Strokes And How To Avoid Cerebral Ischemia During The Procedure
	Presenter(s):Ralf R. Kolvenbach, MD Location: Trianon Ballroom, 3rd Floor
8:51 AM - 8:56 AM	Origins Of Intramural Hematomas (IMHs): Why So Many Prove Benign And Do Well With Medical Treatment: When And How To Treat Them With TEVAR
	Presenter(s):Frank J. Criado, MD Location: Trianon Ballroom, 3rd Floor
8:57 AM - 9:03 AM	Panel Discussion
9:03 AM - 9:16 AM	Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 40

SESSION 41 SCHEDULE
Wednesday SESSION 41: OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; INTERESTING NEW DEVICES FOR THEIR TREATMENT Location: Trianon Ballroom, 3rd Floor Moderators:Christopher J. Kwolek, MD, MBA / Gilbert R. Upchurch, MD
x
COMPLEX AAAs AND TAAAs
9:16 AM - 9:21 AM	Does Open Repair Still Remain The Gold Standard For Complex AAA Repair: What The Updated And Good Studies That Bear On This Question Show: It’s Not The Old RCTs (EVAR 1, DREAM And OVER)
	Presenter(s):George Geroulakos, MD, PhD Location: Trianon Ballroom, 3rd Floor
9:22 AM - 9:27 AM	TAAA Repairs For Aneurysms From Dissections And Degenerative Disease Are Best Treated By Combining Open And Endo Techniques: Technical Tips
	Presenter(s):Yamume Tshomba, MD Location: Trianon Ballroom, 3rd Floor
9:28 AM - 9:33 AM	Hybrid Repair Of A TAAA (Proximal Endograft + Distal Open Repair - The Upchurch Procedure): When Is It Indicated; What Are The Advantages And Updated Results
	Presenter(s):Gilbert R. Upchurch, MD / Sal Scali, MD / Dean Arnaoutakis, MD Location: Trianon Ballroom, 3rd Floor
9:34 AM - 9:39 AM	Endovascular Solutions To Effectively Deal With Hostile Neck Anatomy Of AAAs Other Than F/B/EVAR: Why They Should Be Favored
	Presenter(s):Stavros K. Kakkos, MD, PhD Location: Trianon Ballroom, 3rd Floor
9:40 AM - 9:45 AM	French National (Real World) Comparison Of Results Of F/EVAR And Open Repair (ORFEVAR Trial) For The Treatment Of Complex AAA (Juxtarenal, Suprarenal And Type IV TAAAs): Do We Need An RCT
	Presenter(s):Frederic Cochennec, MD, PhD Location: Trianon Ballroom, 3rd Floor
9:46 AM - 9:52 AM	Panel Discussion
9:52 AM - 9:57 AM	Optimal Surveillance Methods And Timing After F/B/EVAR And EVAR
	Presenter(s):Sara L. Zettervall, MD Location: Trianon Ballroom, 3rd Floor
9:58 AM - 10:03 AM	Secondary Interventions Up To 30 Days Following F/B/EVAR Of Complex AAAs: How Morbid Are They
	Presenter(s):Jonathan R. Boyle, MD, MA (Cantab) FRCS Location: Trianon Ballroom, 3rd Floor
TOPICS RELATED TO INTERESTING NEW DEVICES
10:04 AM - 10:09 AM	Shape Memory Polymer Embolization Devices To Treat Gutter Endoleaks After Parallel Grafts: Technique And Results
	Presenter(s):James F. McKinsey, MD Location: Trianon Ballroom, 3rd Floor
10:10 AM - 10:15 AM	Update On The TAMBE Endograft Device (Gore) For Treating Complex AAAs And TAAAs: Current Configuration And Advantages, Technique For Insertion: Now Approved By The FDA
	Presenter(s):Carlos H. Timaran, MD Location: Trianon Ballroom, 3rd Floor
10:16 AM - 10:21 AM	Update On The WeFlow Device For Juxtarenal AAA, TAAA And Arch Repairs: A New Inner Branch And Outer Branch Approach: How Does It Work And Promising Results
	Presenter(s):Wei Guo, MD Location: Trianon Ballroom, 3rd Floor
10:22 AM - 10:27 AM	How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur – Endo, Open
	Presenter(s):Manju Kalra, MBBS Location: Trianon Ballroom, 3rd Floor
10:28 AM - 10:33 AM	Use Of FORS Technology (Philips) In The Treatment Of TAAAs: Technical Tips In Its Use: What Are Its Advantages, Limitations And Disadvantages
	Presenter(s):Geert Willem H. Schurink, MD, PhD Location: Trianon Ballroom, 3rd Floor
10:34 AM - 10:40 AM	Panel Discussion
END OF SESSION 41

SESSION 42 SCHEDULE
Wednesday SESSION 42: PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS Location: Trianon Ballroom, 3rd Floor Moderators:Thomas S. Maldonado, MD / Rodney A. White, MD / ShenMing Wang, MD, PhD
x
TREATMENT OF ILIAC ANEURYSMS WITH IBDs OR PARALLEL GRAFTS
10:40 AM - 10:45 AM	15-Year Experience With Iliac Branched Endografts For Aortoiliac Aneurysms: Advantages, Limitations: Long-Term Results Of The Various IBD Devices
	Presenter(s):Giovanni Pratesi, MD Location: Trianon Ballroom, 3rd Floor
10:46 AM - 10:51 AM	5-Year Outcomes Of The ICEBERG Study Of The Gore IBD (IBE Device) For Revascularizing The Hypogastric Artery With Aortoiliac Aneurysms: Advantages And Limitations
	Presenter(s):Michel Reijnen, MD, PhD Location: Trianon Ballroom, 3rd Floor
10:52 AM - 10:57 AM	5-Year Outcomes Of The Cook PRESERVE II Study Of The Cook IBD (ZBIS): Why Is It Different From Other IBD Devices: When Is It Contraindicated
	Presenter(s):W. Anthony Lee, MD Location: Trianon Ballroom, 3rd Floor
10:58 AM - 11:03 AM	Advantages And Current Status Of The Artivion IBD Device For Treating Common And Internal Iliac Artery Aneurysms: From The PLIANT II Multicenter Study: When Will This Device Be Available In The US
	Presenter(s):Lee Bouwman, Dr Location: Trianon Ballroom, 3rd Floor
11:04 AM - 11:09 AM	Parallel Endograft Techniques For Treating Common And Internal Iliac Artery Aneurysms: When And Why They Are Better Than IBDs And How To Make Them Work Effectively
	Presenter(s):Armando C. Lobato, MD, PhD Location: Trianon Ballroom, 3rd Floor
11:10 AM - 11:15 AM	Panel Discussion
UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS
11:16 AM - 11:21 AM	Why MLFM Bare Stents Should Be The Treatment Of Choice For Visceral, Peripheral And Iliac Aneurysms: Advantages And Has Rupture Been Universally Prevented: What About For TAAAs
	Presenter(s):Michel C. Henry, MD Location: Trianon Ballroom, 3rd Floor
11:22 AM - 11:27 AM	Treatment Of Aortic Dissections With Multilayer Bare Stents (MLFM) And 9 Years Of Follow Up: When Are They Effective And When Aren’t They
	Presenter(s):Victor S. Costache, MD, PhD / Ivo Petrov, MD, PhD Location: Trianon Ballroom, 3rd Floor
11:28 AM - 11:33 AM	Value Of Multilayer Bare Stents (MLFM – Allay From Intressa) In The Treatment Of TBAD Patients With Or At High Risk Of End Organ Malperfusion: Long-Term Results
	Presenter(s):Claude D. Vaislic, MD Location: Trianon Ballroom, 3rd Floor
11:34 AM - 11:39 AM Power Point Presentation with Synched Audio	Role Of Bare Metal AMDS Stents From Artivion (Formerly Cryolife/Jotec) For Repair Of Acute Type A Dissections: Indications, Results And Limitations
	Presenter(s):Wilson Y. Szeto, MD Location: Trianon Ballroom, 3rd Floor
11:40 AM - 11:45 AM	Thoraflex Hybrid Graft Rescue When Treatment Of Aortic Dissection In The Arch With Bare Stents (AMDS From Artivion And Allay From Intressa) Fails: What Is The Mechanism Of Failure And What Is The Bailout Procedure
	Presenter(s):Mazin Foteh, MD Location: Trianon Ballroom, 3rd Floor
11:46 AM - 11:51 AM	Aortic Dissection In Pregnancy: Why Is The Mortality So High: Why Is Its Diagnosis Delayed: How Should Its Treatment Differ From Non-Pregnant Patients
	Presenter(s):Richard G.J. Gibbs, FRCS Location: Trianon Ballroom, 3rd Floor
11:52 AM - 12:00 PM	Panel Discussion
12:00 PM - 1:00 PM	Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 42

SESSION 43 SCHEDULE
Wednesday SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE Location: Trianon Ballroom, 3rd Floor Moderators:Michael L. Marin, MD / Stephan Haulon, MD
x
1:00 PM - 1:05 PM	Endovascular Strategies For Repairing Giant Hypogastric Artery Aneurysms (>6 cm): What Special Techniques Are Needed
	Presenter(s):Jacques Busquet, MD Location: Trianon Ballroom, 3rd Floor
1:06 PM - 1:11 PM	Debunking The Lingering Myths Of Asymmetrical Saccular Aneurysms: Are They All Ticking Time Bombs, How Should Their Diameter Be Measured – To Include The Normal Aorta Or Not: Do They Rupture At A Smaller Diameter
	Presenter(s):Frank J. Criado, MD Location: Trianon Ballroom, 3rd Floor
1:12 PM - 1:17 PM	A Direct Comparison Of Major Contemporary EVAR Devices – Looking At Long-Term Efficacy And Patient Survival Using Big Data And Linkage Techniques
	Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) Location: Trianon Ballroom, 3rd Floor
1:18 PM - 1:23 PM	EVAR Patients On Anticoagulation Have Increased Mortality, Endoleaks, Sac Expansion And Reinterventions: From A Meta-Analysis Of >35,000 Patients
	Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS Location: Trianon Ballroom, 3rd Floor
1:24 PM - 1:29 PM	Rapid Gate Cannulation During EVAR: A Technical Tip To Make It Quick And Easy
	Presenter(s):Felice Pecoraro, MD Location: Trianon Ballroom, 3rd Floor
1:30 PM - 1:35 PM	Panel Discussion
1:36 PM - 1:41 PM	An RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: The Next Generation Of EVAR Endografts Must Prevent Endoleaks: How Can It Be Done
	Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD Location: Trianon Ballroom, 3rd Floor
1:42 PM - 1:47 PM	Value Of Preemptive Embolization Of AAA Side Branches (IMA And Lumbars) Prior To EVAR: Objective Evidence That It Prevents Sac Enlargement
	Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD Location: Trianon Ballroom, 3rd Floor
1:48 PM - 1:53 PM	How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): How Does A Standard Protocol Help; How To Treat Them When They Occur
	Presenter(s):David J. Minion, MD Location: Trianon Ballroom, 3rd Floor
1:54 PM - 1:59 PM	DEBATE: Repairs Of Small AAAs (<5.5 cm) Are Justified By Many Evidence Based Reasons: What Are These Reasons And What Are The Downsides
	Presenter(s):Jessica P. Simons, MD, MPH Location: Trianon Ballroom, 3rd Floor
2:00 PM - 2:05 PM	DEBATE: There Is High Level Evidence That Men With AAAs <5.5 cm Should NOT Undergo Elective Repair: AAAs < 6 cm In Men Rarely Rupture: The Thresholds For Repair Of Aortic And Iliac Aneurysms Need To Be Raised
	Presenter(s):Anders Wanhainen, MD, PhD Location: Trianon Ballroom, 3rd Floor
2:06 PM - 2:11 PM	Panel Disccusion
END OF SESSION 43

SESSION 44 SCHEDULE
Wednesday SESSION 44: MORE NEW DEVELOPMENTS IN AAAs: WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS): HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR; OTHER RELATED AAA TOPICS Location: Trianon Ballroom, 3rd Floor Moderators:Evan C. Lipsitz, MD, MBA / James H. Black, III, MD
x
TREATMENT OF AORTIC ANEURYSMS WITH HERITABLE AORTIC DISEASE AND CONNECTIVE TISSUE DISORDERS
2:12 PM - 2:17 PM	In Patients With AAAs From Genetic Aortopathy (Heritable Aortic Disease): Is Active Exercise Beneficial Or Harmful
	Presenter(s):James H. Black, III, MD Location: Trianon Ballroom, 3rd Floor
2:18 PM - 2:23 PM	Results Of Endovascular Graft Aortic Repair In Mixed Connective Tissue Disease (Heritable Aortic Disease) Patients: Is It Time To Change The Guidelines: In What Circumstance Is Endovascular Repair Indicated
	Presenter(s):Sal Scali, MD Location: Trianon Ballroom, 3rd Floor
2:24 PM - 2:29 PM	Reasons To Change From Open To Endovascular Aortic Aneurysm Repair In Patients With Heritable Aortic Disease (Connective Tissue Disorders): When Is Open Repair Mandatory In This Setting; Technical Tips
	Presenter(s):Michael J. Jacobs, MD Location: Trianon Ballroom, 3rd Floor
2:30 PM - 2:35 PM	Value Of F/B/EVAR In The Management Of Failed Open Repairs Of Complex AAAs In Patients With Heritable Aortic Disease: Technical Tips
	Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS / Geert Willem H. Schurink, MD, PhD / Michael J. Jacobs, MD Location: Trianon Ballroom, 3rd Floor
2:36 PM - 2:41 PM	Why Selection Of Bridging Stent-Graft Type Is Vitally Important For F/B/EVAR Treatment Of Complex AAAs In Patients With Heritable Aortic Disease: Which Stent-Graft Is Best
	Presenter(s):Gustavo S. Oderich, MD, FACS / Carlos H. Timaran, MD / Andres Schanzer, MD Location: Trianon Ballroom, 3rd Floor
THE EFFECT OF AAA SAC THROMBUS LOAD
2:42 PM - 2:47 PM	DEBATE: Large Flow Luminal Space In An AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective
	Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor
2:48 PM - 2:53 PM	DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity Without Rupture And With Rupture: By What Mechanisms Is Thrombus Harmful And How Can Thrombus Load Be Quantitated
	Presenter(s):David H. Deaton, MD, FACS Location: Trianon Ballroom, 3rd Floor
2:54 PM - 2:59 PM	Update On Technical Tips To Perform SAFE Large Sheath Percutaneous Femoral Access And Closure For Complex AAA EVAR In Obese Or Scarred Groins – Even With Calcified Arteries: It Is Almost Always Possible
	Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS Location: Trianon Ballroom, 3rd Floor
3:00 PM - 3:05 PM	Lessons Learned From The Nellix Experience: Why Sac Sealing Should Still Be Pursued For EVAR, But Not From The Nellix Platform: What Changes Would Make Sac Sealing Devices Work
	Presenter(s):Matt M. Thompson, MD Location: Trianon Ballroom, 3rd Floor
3:06 PM - 3:12 PM	Panel Discussion
3:12 PM - 3:24 PM	Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 44

SESSION 45 SCHEDULE
Wednesday SESSION 45: MORE HOT AORTIC TOPICS Location: Trianon Ballroom, 3rd Floor Moderators:Timothy A.M. Chuter, MD / Peter Gloviczki, MD
x
3:24 PM - 3:29 PM	What's New And What's Wrong With The New SVS Guidelines For Aortic Surgery
	Presenter(s):Michael C. Stoner, MD Location: Trianon Ballroom, 3rd Floor
3:30 PM - 3:35 PM	Aorto-Enteric Fistulas Associated With Infected EVARs Or Open Prosthetic Grafts: What Are The Differences Between Them And What Are The Implications For Treatment
	Presenter(s):Sal Scali, MD Location: Trianon Ballroom, 3rd Floor
3:36 PM - 3:41 PM	Active AAA Sac Management With Polymer Plugs: How To Use Them To Improve Outcomes By Preventing Endoleaks After EVAR: Results From The SHAPE AAA Trial (From Shape Memory)
	Presenter(s):Andrew Holden, MBChB Location: Trianon Ballroom, 3rd Floor
3:42 PM - 3:47 PM	Fenestrated And Branched Graft Treatment Of Failed Open TAAA Repairs
	Presenter(s):Mazin Foteh, MD Location: Trianon Ballroom, 3rd Floor
3:48 PM - 3:53 PM	Aortic Dissection Tear Size And Morphology: Why Is It Important: How Do Bare Stents Prevent Stent-Graft Induced New Entry Tears (SINEs) After Treatment Of Aortic Dissections
	Presenter(s):Shang Loh, MD Location: Trianon Ballroom, 3rd Floor
3:54 PM - 3:59 PM	Panel Discussion
4:00 PM - 4:05 PM	Coil Embolization To Treat Aortic ‘Blebs’, Entry-Tears And Pseudoaneurysms: How Does It Work, When Is It Indicated, And Results
	Presenter(s):Jos C. van den Berg, MD, PhD Location: Trianon Ballroom, 3rd Floor
4:06 PM - 4:11 PM	Endovascular Treatment In Patients With Connective Tissue Disorders: When Can This Be Considered First Choice Treatment: Technical Tips And Results
	Presenter(s):Piergiorgio Cao, MD, FRCS Location: Trianon Ballroom, 3rd Floor
4:12 PM - 4:17 PM	Endovascular Management For Isolated Abdominal Aortic Dissection: When To Treat Invasively And When Not; What To Do If It Involves The Juxtarenal Aorta: How Does Treatment Differ From That Of AAAs
	Presenter(s):Chang Shu, MD Location: Trianon Ballroom, 3rd Floor
4:18 PM - 4:23 PM	What Modifications Of The Distal Components Of F/EVAR Endografts Help To Avoid Branch Vessel Stent-Graft Compression: Indications And Results
	Presenter(s):Nuno V. Dias, MD, PhD Location: Trianon Ballroom, 3rd Floor
4:24 PM - 4:29 PM	Lipophilic Statins Like Lipitor Increase Risk Of Paraplegia More Than Hydrophilic Statins Like Crestor After B/EVAR For TAAA Repairs: What Is The Mechanism
	Presenter(s):Jade S. Hiramoto, MD Location: Trianon Ballroom, 3rd Floor
4:30 PM - 4:35 PM	Panel Discussion
END OF SESSION 45

SESSION 46 SCHEDULE
Wednesday SESSION 46: MORE SHORT HOT NEW TOPICS RELATED TO AORTC DISEASE AND ITS TREATMENT Location: Trianon Ballroom, 3rd Floor Moderators:Andres Schanzer, MD / Peter F. Lawrence, MD
x
4:36 PM - 4:41 PM	DEBATE Round 3: The Vast Majority Of Failed EVARs Can Be Treated Endovascularly
	Presenter(s):Ross Milner, MD Location: Trianon Ballroom, 3rd Floor
4:42 PM - 4:47 PM	DEBATE Round 3: Not So: Many Failed EVARs Are Best Repaired By Open Conversion
	Presenter(s):Michel Makaroun, MD Location: Trianon Ballroom, 3rd Floor
4:48 PM - 4:53 PM	Are Low Profile Devices For EVAR And TEVAR Improving Or Worsening Their Outcomes
	Presenter(s):Naoki Fujimura, MD, PhD Location: Trianon Ballroom, 3rd Floor
4:54 PM - 4:59 PM	There Is No Doubt AAA Screening Saves Lives: Do We Need Changes In The Screening Criteria
	Presenter(s):Maarit Venermo, MD, PhD Location: Trianon Ballroom, 3rd Floor
5:00 PM - 5:05 PM	What Is The AS-Score And How Does It Influence SCI Risk After Endovascular TAAA Repair: What Can Be Done To Offset This
	Presenter(s):Tilo Koelbel, MD, PhD Location: Trianon Ballroom, 3rd Floor
5:06 PM - 5:11 PM	What Are The Differences Between The ACC/AHA And The European Guidelines On Ascending Aorta And Arch Disease
	Presenter(s):Ourania Preventza, MD Location: Trianon Ballroom, 3rd Floor
5:12 PM - 5:17 PM	Panel Discussion
5:18 PM - 5:23 PM	10 Years Of PMEGs For Complex AAAs: How Do The Results Vary With And Without An IDE, The Extent Of The AAA And With And Without A Prior EVAR
	Presenter(s):Marc L. Schermerhorn, MD Location: Trianon Ballroom, 3rd Floor
5:24 PM - 5:29 PM	With Esophageal Cancer, When Is Prophylactic TEVAR Indicated To Prevent An Aorto-Esophageal Fistula: It Improves Palliation But Does It improve Survival
	Presenter(s):I-Hui Wu, MD, PhD Location: Trianon Ballroom, 3rd Floor
5:30 PM - 5:35 PM	Small Tips And Modifications In Radiation Safety Can Make A Huge Impact On Staff Exposure: What Are They And How Can They Be Enforced
	Presenter(s):Maarit Venermo, MD, PhD Location: Trianon Ballroom, 3rd Floor
5:36 PM - 5:41 PM	Pediatric Abdominal Aortic Aneurysms: What Is Their Etiology And How Should They Be Managed
	Presenter(s):Sherene Shalhub, MD, MPH Location: Trianon Ballroom, 3rd Floor
5:42 PM - 5:47 PM	B/EVAR In Patients With A Narrow Paravisceral Aorta (<2.5 cm) Is Best Performed With Inner Branched Endografts: Technical Tips To Achieve Optimal Results
	Presenter(s):Michele Antonello, MD, PhD / Franco Grego, MD Location: Trianon Ballroom, 3rd Floor
5:48 PM - 5:53 PM	ZFEN Versus Treo Endografts As Platforms For PMEG F/EVARs: Which Is Best And When: Technical Considerations, Advantages And Disadvantages
	Presenter(s):Joshua D. Adams, MD Location: Trianon Ballroom, 3rd Floor
5:54 PM - 5:59 PM	When Can Duplex Ultrasound Fully Replace CT Surveillance After EVAR: When Is CT Surveillance Necessary
	Presenter(s):Sal Scali, MD Location: Trianon Ballroom, 3rd Floor
6:00 PM - 6:10 PM	Panel Discussion End of Program F
END OF SESSION 46